NCT03211611

Management of Women With BRCA1/2 Mutation

Role of General Practionners in Management of Women With BRCA1/2 Mutation

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 600 (actual)
• Sponsor: University Hospital, Montpellier · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation. This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

Detailed description

PURPOSE: The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation. METHODS: This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

Conditions

• BRCA1 Mutation
• BRCA2 Mutation

Interventions

Type	Name	Description
BEHAVIORAL	Questionnaire given to the two groups	Questionnaire given to the two groups : Patients with BRCA ½ mutation GP

Timeline

• Start date: 2017-04-01
• Primary completion: 2017-08-31
• Completion: 2017-11-01
• First posted: 2017-07-07
• Last updated: 2018-05-07

Locations

1 site across 1 country: France